Time point | Enrolment pretreatment | Allocation | Baseline (T0) | 2 weeks post treatment (T1) | Daily documentation | 3-week follow-up (FU1) | 6- and 12-month follow-up (FU2–3) |
---|---|---|---|---|---|---|---|
Enrolment | |||||||
Eligibility screening | x | Â | Â | Â | Â | Â | Â |
Informed consent | x | Â | Â | Â | Â | Â | Â |
Allocation | x | x | Â | Â | Â | Â | Â |
Interventions | |||||||
Physiotherapy | Â | Â | x | x | x | x | Â |
Occupational | Â | Â | x | x | x | x | Â |
therapy | Â | Â | Â | Â | Â | Â | Â |
Other therapies (e.g. groups) | Â | Â | x | x | x | x | Â |
Additional | Â | Â | x | x | Â | Â | Â |
interventions | Â | Â | x | x | Â | Â | Â |
Primary outcome | |||||||
FAC score | Â | Â | x | x | x | x | x |
FSS-ICU | Â | Â | x | x | Â | x | x |
Secondary outcomes | |||||||
STS | Â | Â | x | x | x | x | x |
MRC sum score | Â | Â | x | x | Â | x | Â |
Grip strength | Â | Â | x | x | Â | x | Â |
PFIT-S | Â | Â | x | x | Â | Â | Â |
EQ-5D | Â | Â | Â | Â | Â | x | x |
RNL-Index | Â | Â | Â | Â | Â | x | x |